
Revolutionizing orthopedic care with our time-saving device, we're setting new standards for joint surgeries and patient recovery.
Simparo Surgical, founded by a team of four partners with nearly 90 years of collective experience in orthopedic device design, manufacture, and commercialization, aims to revolutionize orthopedic care. The company focuses on the extremity marketplace, offering innovative surgical devices like the Anchor Line Fixation System with Falcon Suture Clutch Technology. This device significantly reduces procedural time by over 65% and promotes faster patient recovery, setting new standards for joint surgeries and patient care.
Notable affiliated individuals include the founding partners, whose extensive experience has been crucial in the development and commercialization of the company's products. Simparo Surgical has achieved significant milestones, such as creating a new standard of care for the most operated joint in the hand and expanding procedures and biologic applications to replace traditional implant arthroplasty methods. The company's impact is evident in its ability to streamline surgical processes and improve patient outcomes, making it a key player in the orthopedic surgical device industry.

Surgimatix
surgimatix.com

Parvizi Surgical Innovation

Edge Surgical
edgesurgical.com

Amplify Surgical

Buck Surgical
bucksurgical.com

Simpirica Spine
simpirica.com

OnPoint Surgical

Emet Surgical
emetsurgical.com

Think Surgical
thinksurgical.com

surgical.ai
surgical.ai

Seguro Surgical

Surgrx

Symple Surgical

Innovo Surgical
innovosurgical.com

New View Surgical
newviewsurg.com
Companies similar to Simparo Surgical include Surgimatix, Parvizi Surgical Innovation, Edge Surgical and Amplify Surgical.
Simparo Surgical was founded in 2021.
Simparo Surgical's headquarters is located in Mobile, AL, US.
Simparo Surgical's most recent funding round was for $2.4M (USD) in December 2023.
As of Dec 14, 2023, Simparo Surgical has raised a total of $2.4M (USD).
Simparo Surgical has 2 employees as of Feb 4, 2024.